covid pfizer - Search News

Order byBest matchMost fresh

FDA, COVID

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct...

· 44m

FDA’s new approach raises questions about fall COVID vaccine availability

· 16h · on MSN

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

· 2h

The FDA’s new COVID-19 vaccine policy, explained

The FDA announced a new COVID-19 vaccine policy yesterday limiting access to adults ages 65 and over and others at high risk, and raising questions about who will be able to get one this fall.

· 20h

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

· 22h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

21m

Biden officials knew about, downplayed risks from COVID-19 vaccines, Senate report claims

Top health officials were aware of and actively took steps to “delay warning the public” for months in 2021 about the potential risks of patients suffering from heart-related

13hon MSN

FDA sets new COVID booster guidelines for healthy adults under 65

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Zacks Investment Research on MSN1h

MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots

Shares of prominent COVID-19 vaccine-makers Moderna MRNA, Pfizer PFE and BioNTech BNTX rose yesterday after the FDA issued new guidance for COVID-19 vaccine boosters. FDA’s New Requirements for COVID-19 Vaccines Although the agency continues to approve boosters based on immune response data for adults 65 and older,

Pfizer scientist claimed COVID vax results being delayed until after 2020 election ‘wasn’t a coincidence’: House GOP panel

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public

5don MSN

New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations provided by a rival drugmaker.

16h

F.D.A. Poised to Restrict Access to Covid Vaccines

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.

Pfizer: Better To Face The Harsh Reality Than Continue Waiting

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click to find out why PFE stock is a Hold.

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the development, manufacturing and commercialization of a drug undergoing trials for treatment of certain types of cancer and tumours,